2020
DOI: 10.1101/2020.04.20.20064105
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Clinical and Imaging Findings in COVID-19 Patients Complicated by Pulmonary Embolism

Abstract: All the authors have no conflicts of interest to disclose. AcknowledgementWe thank Sudhakar, Pipavath in University of Washington for his valuable contribution in editing the manuscript. AbstractObjective: To describe clinical, and imaging findings including the evolution pattern in COVID-19 pneumonia complicated by pulmonary embolism (PE). Methods:Eleven of 1453 patients with a probable diagnosis of COVID-19 pneumonia were retrospectively selected for the presence of PE. Clinical and laboratory data were reco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 28 publications
1
1
0
Order By: Relevance
“…PE, in our study, was most frequently observed in the subsegmental and segmental pulmonary arteries, or both (75%), whereas the remaining cases were distributed between multisegmented, lobar, and massive PE. This finding agrees with previous studies that reported that PE in COVID-19 is more typically identified in the peripheral parts of the lungs [ 34 – 39 ], which is compatible with the observation of microthrombi formation [ 38 , 39 ]. These sites also tend to conform to the most typical COVID-19 opacity distribution [ 38 ]; however, other studies have also reported massive PE among COVID-19 patients [ 27 , 40 ].…”
Section: Discussionsupporting
confidence: 93%
“…PE, in our study, was most frequently observed in the subsegmental and segmental pulmonary arteries, or both (75%), whereas the remaining cases were distributed between multisegmented, lobar, and massive PE. This finding agrees with previous studies that reported that PE in COVID-19 is more typically identified in the peripheral parts of the lungs [ 34 – 39 ], which is compatible with the observation of microthrombi formation [ 38 , 39 ]. These sites also tend to conform to the most typical COVID-19 opacity distribution [ 38 ]; however, other studies have also reported massive PE among COVID-19 patients [ 27 , 40 ].…”
Section: Discussionsupporting
confidence: 93%
“…It is these same inflammatory cytokines that initiate the formation of a pro-coagulopathic state (Levi et al, 2020). This cascading effect may explain why Li et al (2020a) found an increase in pulmonary embolism rates in those who are critically ill with COVID-19 disease. There is also evidence of perfusion defects as a result of pulmonary microthrombi (Fogarty et al, 2020), described as a 'pulmonary vasculopathy'.…”
Section: Pathophysiologymentioning
confidence: 99%